As of 2026-06-07, the EV/EBITDA ratio of SonoScape Medical Corp (300633.SZ) is 52.14. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. 300633.SZ's latest enterprise value is 7,565.14 mil CNY. 300633.SZ's TTM EBITDA according to its financial statements is 145.10 mil CNY. Dividing these 2 quantities gives us the above 300633.SZ EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 25.2x - 39.3x | 30.6x |
| Forward P/E multiples | 15.1x - 16.0x | 15.7x |
| Fair Price | 11.00 - 16.71 | 14.65 |
| Upside | -45.1% - -16.7% | -27.0% |
| Date | EV/EBITDA |
| 2026-06-01 | 53.69 |
| 2026-05-29 | 53.18 |
| 2026-05-28 | 54.82 |
| 2026-05-27 | 55.45 |
| 2026-05-26 | 56.73 |
| 2026-05-25 | 57.57 |
| 2026-05-22 | 58.13 |
| 2026-05-21 | 59.50 |
| 2026-05-20 | 59.30 |
| 2026-05-19 | 60.10 |
| 2026-05-18 | 59.65 |
| 2026-05-15 | 61.06 |
| 2026-05-14 | 62.10 |
| 2026-05-13 | 63.86 |
| 2026-05-12 | 62.40 |
| 2026-05-11 | 64.13 |
| 2026-05-08 | 64.16 |
| 2026-05-07 | 64.34 |
| 2026-05-06 | 63.95 |
| 2026-04-30 | 64.96 |
| 2026-04-29 | 64.81 |
| 2026-04-28 | 68.84 |
| 2026-04-27 | 71.79 |
| 2026-04-24 | 72.48 |
| 2026-04-23 | 74.74 |
| 2026-04-22 | 75.31 |
| 2026-04-21 | 76.15 |
| 2026-04-20 | 76.29 |
| 2026-04-17 | 76.41 |
| 2026-04-16 | 73.73 |
| 2026-04-15 | 72.36 |
| 2026-04-14 | 71.58 |
| 2026-04-13 | 71.05 |
| 2026-04-10 | 71.11 |
| 2026-04-09 | 69.35 |
| 2026-04-08 | 69.58 |
| 2026-04-07 | 67.26 |
| 2026-04-03 | 67.14 |
| 2026-04-02 | 69.41 |
| 2026-04-01 | 70.54 |
| 2026-03-31 | 68.57 |
| 2026-03-30 | 67.53 |
| 2026-03-27 | 65.86 |
| 2026-03-26 | 64.01 |
| 2026-03-25 | 65.02 |
| 2026-03-24 | 63.59 |
| 2026-03-23 | 62.22 |
| 2026-03-20 | 66.60 |
| 2026-03-19 | 68.69 |
| 2026-03-18 | 70.48 |